• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化的营养评估:一项前瞻性多中心研究。

Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study.

作者信息

Faverio Paola, Fumagalli Alessia, Conti Sara, Madotto Fabiana, Bini Francesco, Harari Sergio, Mondoni Michele, Oggionni Tiberio, Barisione Emanuela, Ceruti Paolo, Papetti Maria Chiara, Bodini Bruno Dino, Caminati Antonella, Valentino Angela, Centanni Stefano, Noè Donatella, Della Zoppa Matteo, Crotti Silvia, Grosso Marco, Sukkar Samir Giuseppe, Modina Denise, Andreoli Marco, Nicali Roberta, Suigo Giulia, De Giacomi Federica, Busnelli Sara, Cattaneo Elena, Mantovani Lorenzo Giovanni, Cesana Giancarlo, Pesci Alberto, Luppi Fabrizio

机构信息

Respiratory Unit, School of Medicine and Surgery, University of Milano Bicocca, San Gerardo Hospital, ASST Monza, Monza, Italy.

These authors contributed equally.

出版信息

ERJ Open Res. 2022 Mar 7;8(1). doi: 10.1183/23120541.00443-2021. eCollection 2022 Jan.

DOI:
10.1183/23120541.00443-2021
PMID:35265706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8899499/
Abstract

BACKGROUND

Nutritional status impacts quality of life and prognosis of patients with respiratory diseases, including idiopathic pulmonary fibrosis (IPF). However, there is a lack of studies performing an extensive nutritional assessment of IPF patients. This study aimed to investigate the nutritional status and to identify nutritional phenotypes in a cohort of IPF patients at diagnosis.

METHODS

Patients underwent a thorough pulmonary and nutritional evaluation including questionnaires on nutritional status, and physical activity, anthropometry, body impedance, dynamometry, 4-m gait speed and blood tests.

RESULTS

90 IPF patients (78.9% males, mean age 72.7 years) were enrolled. The majority of patients were classified as Gender-Age-Physiology Index stage 2 (47, 52.2%) with an inactive lifestyle according to International Physical Activity Questionnaire score (39, 43.3%), and had mean forced vital capacity and diffusing capacity for carbon monoxide 86.5% and 54.2%, respectively. In regards to nutritional phenotypes, the majority of patients were normally nourished (67.8%, 95% CI 58.6-77.7%), followed by non-sarcopenic obese (25.3%, 95% CI 16.1-35.2%), sarcopenic (4.6%, 95% CI 0.0-14.5%) and sarcopenic obese (2.3%, 95% CI 0.0-12.2%). Among the normally nourished, 49.2% showed early signs of nutritional and physical performance alterations, including body mass index ≥30 kg·m in 4.3%, history of weight loss ≥5% in 11.9%, and reduction of gait speed and hand grip strength in 11.9% and 35.6%, respectively. Low vitamin D values were observed in 56.3% of cases.

CONCLUSIONS

IPF patients at diagnosis are mainly normally nourished and obese, but early signs of nutritional and physical performance impairment can already be identified at this stage.

摘要

背景

营养状况会影响包括特发性肺纤维化(IPF)在内的呼吸系统疾病患者的生活质量和预后。然而,缺乏对IPF患者进行全面营养评估的研究。本研究旨在调查一组IPF患者在诊断时的营养状况并确定营养表型。

方法

患者接受了全面的肺部和营养评估,包括关于营养状况、身体活动的问卷调查,人体测量、身体阻抗、握力测试、4米步速测试和血液检查。

结果

纳入了90例IPF患者(男性占78.9%,平均年龄72.7岁)。根据国际体力活动问卷评分,大多数患者被归类为性别-年龄-生理指数2期(47例,52.2%),生活方式不活跃(39例,43.3%),平均用力肺活量和一氧化碳弥散量分别为86.5%和54.2%。关于营养表型,大多数患者营养正常(67.8%,95%可信区间58.6 - 77.7%),其次是非肌肉减少性肥胖(25.3%,95%可信区间16.1 - 35.2%)、肌肉减少症(4.6%,95%可信区间0.0 - 14.5%)和肌肉减少性肥胖(2.3%,95%可信区间0.0 - 12.2%)。在营养正常的患者中,49.2%表现出营养和身体机能改变的早期迹象,包括4.3%的体重指数≥30kg·m²,11.9%的体重减轻史≥5%,以及11.9%和35.6%的步速和握力下降。56.3%的病例维生素D值较低。

结论

IPF患者在诊断时主要营养正常且肥胖,但在此阶段已可识别出营养和身体机能损害的早期迹象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/e3a22eb6c25a/00443-2021.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/9bcb7403b310/00443-2021.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/4fb87b954383/00443-2021.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/70a7a82d218f/00443-2021.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/e3a22eb6c25a/00443-2021.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/9bcb7403b310/00443-2021.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/4fb87b954383/00443-2021.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/70a7a82d218f/00443-2021.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/e3a22eb6c25a/00443-2021.04.jpg

相似文献

1
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study.特发性肺纤维化的营养评估:一项前瞻性多中心研究。
ERJ Open Res. 2022 Mar 7;8(1). doi: 10.1183/23120541.00443-2021. eCollection 2022 Jan.
2
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach.特发性肺纤维化中的肌肉减少症:一项探索患病率、相关因素和诊断方法的前瞻性研究。
Respir Res. 2022 Sep 3;23(1):228. doi: 10.1186/s12931-022-02159-7.
3
Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry.特发性肺纤维化患者的基线特征和生存情况:瑞典特发性肺纤维化登记处的纵向分析。
Respir Res. 2021 Feb 5;22(1):40. doi: 10.1186/s12931-021-01634-x.
4
Physical activity in daily life in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者的日常生活体力活动
Respir Investig. 2018 Jan;56(1):57-63. doi: 10.1016/j.resinv.2017.09.004. Epub 2017 Oct 23.
5
Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.非小细胞肺癌合并肺纤维化肺气肿和特发性肺纤维化:对生存和急性加重的影响。
BMC Pulm Med. 2019 Oct 15;19(1):177. doi: 10.1186/s12890-019-0951-2.
6
Nutritional status and quality of life in interstitial lung disease: a prospective cohort study.间质性肺疾病患者的营养状况和生活质量:一项前瞻性队列研究。
BMC Pulm Med. 2021 Feb 5;21(1):51. doi: 10.1186/s12890-021-01418-5.
7
Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.多次呼吸冲洗:一种用于特发性肺纤维化患者的新型且有前途的肺功能测试。
Respirology. 2018 Aug;23(8):764-770. doi: 10.1111/resp.13294. Epub 2018 Mar 24.
8
Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry.抗纤维化药物在特发性肺纤维化患者中的应用。来自 IPF-PRO 注册研究的数据。
Ann Am Thorac Soc. 2020 Nov;17(11):1413-1423. doi: 10.1513/AnnalsATS.201912-880OC.
9
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.特发性肺纤维化合并轻度生理损害的疾病进展:来自澳大利亚特发性肺纤维化登记处的分析。
BMC Pulm Med. 2018 Jan 25;18(1):19. doi: 10.1186/s12890-018-0575-y.
10
Gastroesophageal reflux disease and patterns of reflux in patients with idiopathic pulmonary fibrosis using hypopharyngeal multichannel intraluminal impedance.使用下咽多通道腔内阻抗检测特发性肺纤维化患者的胃食管反流病及反流模式
Dis Esophagus. 2014 Aug;27(6):530-7. doi: 10.1111/j.1442-2050.2012.01446.x. Epub 2012 Oct 26.

引用本文的文献

1
Nutritional insights into pulmonary fibrosis: a comprehensive review on the impact of vitamins.肺纤维化的营养见解:关于维生素影响的综合综述
Front Nutr. 2025 Apr 11;12:1525408. doi: 10.3389/fnut.2025.1525408. eCollection 2025.
2
The Nutritional Phenotyping of Idiopathic Pulmonary Fibrosis Through Morphofunctional Assessment: A Bicentric Cross-Sectional Case-Control Study.通过形态功能评估对特发性肺纤维化进行营养表型分析:一项双中心横断面病例对照研究。
Life (Basel). 2025 Mar 21;15(4):516. doi: 10.3390/life15040516.
3
Assessing causal relationships between diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomisation study.

本文引用的文献

1
Nutritional status and quality of life in interstitial lung disease: a prospective cohort study.间质性肺疾病患者的营养状况和生活质量:一项前瞻性队列研究。
BMC Pulm Med. 2021 Feb 5;21(1):51. doi: 10.1186/s12890-021-01418-5.
2
Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis.分析体重指数、体重减轻与特发性肺纤维化进展的关系。
Respir Res. 2020 Nov 25;21(1):312. doi: 10.1186/s12931-020-01528-4.
3
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
评估糖尿病与特发性肺纤维化之间的因果关系:一项孟德尔随机化研究。
Thorax. 2025 Feb 17;80(3):133-139. doi: 10.1136/thorax-2024-221472.
4
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.肺纤维化的遗传学和基因组学:描绘分子图谱,塑造精准医学。
Am J Respir Crit Care Med. 2024 Aug 15;210(4):401-423. doi: 10.1164/rccm.202401-0238SO.
5
Endocrine and metabolic factors and the risk of idiopathic pulmonary fibrosis: a Mendelian randomization study.内分泌和代谢因素与特发性肺纤维化风险:一项孟德尔随机研究。
Front Endocrinol (Lausanne). 2024 Jan 8;14:1321576. doi: 10.3389/fendo.2023.1321576. eCollection 2023.
6
Ectopic and visceral fat deposition in aging, obesity, and idiopathic pulmonary fibrosis: an interconnected role.衰老、肥胖和特发性肺纤维化中异位和内脏脂肪沉积:相互关联的作用。
Lipids Health Dis. 2023 Nov 24;22(1):201. doi: 10.1186/s12944-023-01964-3.
7
Fibroblast Upregulation of Vitamin D Receptor Represents a Self-Protective Response to Limit Fibroblast Proliferation and Activation during Pulmonary Fibrosis.成纤维细胞中维生素D受体的上调代表了一种自我保护反应,以限制肺纤维化过程中成纤维细胞的增殖和激活。
Antioxidants (Basel). 2023 Aug 18;12(8):1634. doi: 10.3390/antiox12081634.
8
Vitamin D and idiopathic pulmonary fibrosis: a two-sample mendelian randomization study.维生素 D 与特发性肺纤维化:两样本孟德尔随机化研究。
BMC Pulm Med. 2023 Aug 23;23(1):309. doi: 10.1186/s12890-023-02589-z.
9
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis.体力活动测量在间质性肺疾病患者中的应用:系统评价和荟萃分析。
Eur Respir Rev. 2023 Jul 12;32(169). doi: 10.1183/16000617.0165-2022. Print 2023 Sep 30.
10
Protective effect of BB536 against nausea caused by pirfenidone in a mouse model of pellagra.BB536对吡非尼酮在糙皮病小鼠模型中引起的恶心的保护作用。
Biosci Microbiota Food Health. 2023;42(3):195-202. doi: 10.12938/bmfh.2022-042. Epub 2023 Mar 9.
特发性肺纤维化患者接受抗纤维化治疗的死亡率和肌肉减少症的原因。
Respirology. 2021 Feb;26(2):171-179. doi: 10.1111/resp.13943. Epub 2020 Sep 23.
4
Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions.特发性肺纤维化患者的营养问题:关键问题分析与未来研究方向
Nutrients. 2020 Apr 17;12(4):1131. doi: 10.3390/nu12041131.
5
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
6
What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center.评估特发性肺纤维化患者营养不良的最佳指标是什么?一家转诊中心的横断面研究。
Nutrition. 2019 Jun;62:115-121. doi: 10.1016/j.nut.2018.12.008. Epub 2018 Dec 19.
7
Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis.维生素 D 可预防实验性肺纤维化,并可预测特发性肺纤维化患者的生存率。
Pulm Pharmacol Ther. 2019 Apr;55:17-24. doi: 10.1016/j.pupt.2019.01.003. Epub 2019 Jan 16.
8
Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study.特发性肺纤维化患者的步态速度与预后:一项前瞻性队列研究。
Eur Respir J. 2019 Feb 7;53(2). doi: 10.1183/13993003.01186-2018. Print 2019 Feb.
9
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
10
The Clinical Significance of Body Weight Loss in Idiopathic Pulmonary Fibrosis Patients.特发性肺纤维化患者体重减轻的临床意义。
Respiration. 2018;96(4):338-347. doi: 10.1159/000490355. Epub 2018 Aug 21.